Association of vaping-related lung injuries with rates of e-cigarette and cannabis use across US states.

ABSTRACT:

Background and aims

Responses to the 2019 US outbreak of 'e-cigarette or vaping product use-associated lung injury' (EVALI) ranged from temporary restrictions on nicotine e-cigarette sales to critiques of state cannabis policies. However, if either mass-marketed nicotine e-cigarettes or cannabis use per se drove this outbreak, as opposed to an additive in regionally available black-market e-liquids, states' rates of vaping and/or cannabis use should predict their EVALI prevalence. This study tests that relationship.

Design

Observational study of EVALI data from US states' health departments SETTING: United States.

Participants

All US states (n = 50).

Measurements

The outcome of interest was each state's total EVALI cases per 12-64-year-old resident-an age group

SUBMITTER: Friedman AS 

PROVIDER: S-EPMC7878297 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature